This is a partial preview. Full document is 29 slides. View large preview.
EMBED CODE (Copy and Paste)
The multiple myeloma market will witness an impressive 10% annual growth over 2015-2025, with major-market sales increasing from $8.6 billion in 2015 to $22.3 billion in 2025. Growth will be fueled by the continued uptake and label expansions of current therapies and the expected market entry of four novel, premium-priced therapies. Immunomodulatory agents are, and will remain, the dominant drug class throughout the forecast period and will capture more than 50% of major-market sales in 2025.
Got a question about the product? Email us at [email protected] or ask the author directly by using the form to the right. If you cannot view the preview above this document description, go here to view the large preview instead.
Source: Pharma Disease Insight: Multiple Myeloma PowerPoint document
Pharma Disease Insight: Multiple Myeloma
This business document is categorized under the function(s): None specified.
File Size: 1.9 MB
Number of Slides: 29
Purchase includes lifetime product updates. After your purchase, you will receive an email to download this document.
Initial upload date (first version): Jun 8, 2017
Ask the Author a Question
Log In Below
Report this Document
Please explain why the content is inappropriate and provide as much detail as possible. Possible reasons include, but are not limited, to the following:
Are you a business professional?
Just as the mobile apps market has helped software developers earn sustainable, passive income, we hope Flevy will do the same for business professionals, like yourself. There's no reason to let your IP collect dust when it can be making you perpetual income.
CUSTOMERS ALSO BOUGHT THESE DOCUMENTS